Apolipoprotein E ε2 is associated with new hemorrhage risk in brain arteriovenous malformations

Neurosurgery

Volumn 58, Issue 5, 2006, Pages 838-842

  Pawlikowska, Ludmila ^a   Poon, K Y Trudy ^b   Achrol, Achal S ^b   McCulloch, Charles E ^b   Ha, Connie ^a   Lum, Kristen ^a   Zaroff, Jonathan C ^b   Ko, Nerissa U ^b   Johnston, S Claiborne ^a   Sidney, Stephen ^c   Marchuk, Douglas A ^d   Lawton, Michael T ^b   Kwok, Pui Yan ^a   Young, William L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DIVISION OF RESEARCH   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cerebral hemorrhage; Genetic epidemiology; Vascular malformations

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E;

ADULT; ARTICLE; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; COHORT ANALYSIS; FEMALE; FOLLOW UP; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SURGICAL RISK; ARTERIOVENOUS MALFORMATION; COMPARATIVE STUDY; GENETICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTOR; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; APOLIPOPROTEIN E2; APOLIPOPROTEINS E; ARTERIOVENOUS MALFORMATIONS; FEMALE; GENOTYPE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RISK FACTORS;

EID: 33646822471     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000209605.18358.E5     Document Type: Article

References (22)

1. Achrol AS, Pawlikowska L, McCulloch CE, Poon KYT, Ha C, Zaroff JG, Johnston SC, Lee C, Lawton MT, Sidney S, Marchuk DA, Kwok PY, Young WL: Tumor necrosis factor-α-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations. Stroke 37:231-234, 2006.
2. Biehle SJ, Carrozzella J, Shukla R, Popplewell J, Swann M, Freeman N, Clark JF: Apolipoprotein E isoprotein-specific interactions with tissue plasminogen activator. Biochim Biophys Acta 1689:244-251, 2004.
3. Broderick J, Lu M, Jackson C, Pancioli A, Tilley BC, Fagan SC, Kothari R, Levine SR, Marler JR, Lyden PD, Haley EC Jr, Brott T, Grotta JC: Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke. Ann Neurol 49:736-744, 2001.
4. Choi JH, Mohr JP: Brain arteriovenous malformations in adults. Lancet Neurol 4:299-308, 2005.
5. Clark JF, Huri DA, Carrozzella J, Jauch EC, Mehta P, Heaton D, Biehle SJ, Broderick JP: Isoforms of apolipoprotein E can modulate tPA-induced clot lysis in vitro. Front Biosci 7:163-168, 2002.
6. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC: Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review. Am J Epidemiol 155:487-495, 2002.
7. Fleetwood IG, Steinberg GK: Arteriovenous malformations. Lancet 359:863-873, 2002.
8. Fullerton HJ, Achrol AS, Johnston SC, McCulloch CE, Higashida RT, Lawton MT, Sidney S, Young WL: Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke 36:2099-2104, 2005.
9. Halim AX, Johnston SC, Singh V, McCulloch CE, Bennett JP, Achrol AS, Sidney S, Young WL: Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke 35:1697-1702, 2004.
10. Halim AX, Singh V, Johnston SC, Higashida RT, Dowd CF, Halbach VV, Lawton MT, Gress DR, McCulloch CE, Young WL: Characteristics of brain arteriovenous malformations with coexisting aneurysms: A comparison of two referral centers. Stroke 33:675-679, 2002.
11. Hashimoto T, Wen G, Lawton MT, Boudreau NJ, Bollen AW, Yang GY, Barbara NM, Higashida RT, Dowd CF, Halbach W, Young WL: Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke 34:925-931, 2003.
12. Hsu TM, Kwok PY: Homogeneous primer extension, assay with fluorescence polarization detection. Methods Mol Biol 212:177-187, 2003.
13. Joint Writing Group of the Technology Assessment Committee ASoIaTN, Joint Section on Cerebrovascular Neurosurgery, a section of American Association of Neurological Surgeons and Congress of Neurological Surgeons, and Section of Stroke and the Section of Interventional Neurology of the American Academy of Neurology: Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke 32:1430-1442, 2001.
14. Koistinaho M, Koistinaho J: Interactions between Alzheimer's disease and cerebral ischemia-focus on inflammation. Brain Res Brain Res Rev 48:240-250, 2005.
15. Leung CH, Poon WS, Yu LM, Wong GK, Ng HK: Apolipoprotein e genotype and outcome in aneurysmal subarachnoid hemorrhage. Stroke 33:548-552, 2002.
16. Lo EH, Dalkara T, Moskowitz MA: Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4:399-415, 2003.
17. Mast H, Young WL, Koennecke HC, Sciacca RR, Osipov A, Pile-Spellman J, Hacein-Bey L, Duong H, Stein BM, Mohr JP: Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet 350:1065-1068, 1997.
18. McCarron MO, Weir CJ, Muir KW, Hoffmann KL, Graftagnino C, Nicoll JA, Lees KR, Alberts MJ: Effect of apolipoprotein E genotype on in-hospital mortality following intracerebral haemorrhage. Acta Neurol Scand 107:106-109, 2003.
19. O'Donnell HC, Rosand J, Knudsen KA, Furie KL, Segal AZ, Chiu RI, Ikeda D, Greenberg SM: Apolipoprotein E genotype and the risk of recurrent lobar intracranial hemorrhage. N Engl J Med 342:240-245, 2000.
20. Pawlikowska L, Tran MN, Achrol AS, McCulloch CE, Ha C, Lind DL, Hashimoto T, Zaroff J, Lawton MT, Marchuk DA, Kwok P-Y, Young WL: Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations. Stroke 35:2294-2300, 2004.
21. Wiebers DO, Whisnant JP, Huston J, Meissner I, Brown RD, Piepgras DG, Forbes GS, Thielen K, Nichols D, O'Fallon WM, Peacock J, Jaeger L, Kassell NF, Kongable-Beckman GL, Torner JC: Unruptured intracranial aneurysms: Natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 362:103-110, 2003.
22. Woo D, Sauerbeck LR, Kissela BM, Khoury JC, Szatlarski JP, Gebel J, Shukla R, Pancioli AM, Jauch EC, Menon AG, Deka R, Carrozzella JA, Moomaw CJ, Fontaine RN, Broderick JP: Genetic and environmental risk factors for intracranial hemorrhage: Preliminary results of a population-based study. Stroke 33:1190-1196, 2002.